These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3458017)

  • 1. [The behavior of blood CA 15.3 in patients with non-tumor pathologies. Preliminary results].
    Ruibal A; Guarga A; Encabo G; Gris JM
    Med Clin (Barc); 1986 Feb; 86(6):262. PubMed ID: 3458017
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum CA 15.3 in women with non-tumor breast pathologies. Initial results].
    Ruibal A; Colomer R; Gris JM; Genollá J
    Med Clin (Barc); 1986 Sep; 87(9):393-4. PubMed ID: 3467152
    [No Abstract]   [Full Text] [Related]  

  • 3. Seric CA 19.9 levels in patients with non tumoral pathologies. Our experience in 892 cases.
    Encabo G; Ruibal A
    Bull Cancer; 1986; 73(3):256-9. PubMed ID: 3463370
    [No Abstract]   [Full Text] [Related]  

  • 4. [Behavior of serum CA 72.4 in patients with non-tumor pathologies. Preliminary results].
    Sagredo E; Soriano A; Pombo L; Ruibal A
    Med Clin (Barc); 1989 Jan; 92(2):78-9. PubMed ID: 2709892
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum CA 1,25 in patients with non-ovarian tumors. Evidence of a relation between the increase of the antigen and hepatic disease].
    Ruibal A; Siurana R; Encabo G; Cuartero A
    Med Clin (Barc); 1985 Mar; 84(9):376-7. PubMed ID: 3857424
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum CA 19-9 and CA 50 antigens in hemodialysis patients.
    Docci D; Pistocchi E; Turci F; Baldrati L; Urbini S; Scaioli S
    Clin Nephrol; 1987 Apr; 27(4):179-81. PubMed ID: 3472698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of carbohydrate antigen 19-9 in the adult and the child. Preliminary results].
    Capocasale E; Banchini B; Nori G; de Angelis GL; Gregori G
    Minerva Dietol Gastroenterol; 1986; 32(2):135-8. PubMed ID: 3461312
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preliminary study on detecting the CA 125 value in endometrial washings].
    Chen DX; Schwartz PE
    Zhonghua Fu Chan Ke Za Zhi; 1987 Sep; 22(5):288-90, 312. PubMed ID: 3481694
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum CA-125 level in patients with gynecologic tumors].
    Abe Y; Ueda G; Yamasaki M; Inoue M; Hiramatsu K; Inoue Y; Saito J; Nishino T
    Rinsho Byori; 1984 Dec; 32(12):1350-4. PubMed ID: 6597876
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum CA 50 in benign non-hepatic diseases].
    Genollá J; Mañé S; Gris JM; Ruibal A
    Med Clin (Barc); 1987 Feb; 88(5):214. PubMed ID: 3470582
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical significance of serum CA 19-9 in patients with gastric and colorectal carcinoma and immunohistochemical visualization of CA 19-9 in tumor tissues.
    Sekikawa K
    Fukushima J Med Sci; 1985 Jun; 31(1):29-42. PubMed ID: 3866740
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum CA 15.3 levels in patients with general pathology and malignant diseases (excluding breast cancer).
    Ruibal A; Encabo G; Genollá J; Guarga A; Urrutia A; Colomer R
    Bull Cancer; 1986; 73(1):94-5. PubMed ID: 3465383
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the serum levels of a carbohydrate antigen 19-9 (CA 19-9) in patients with ovarian cancer].
    Miyoshi T; Nishimura H; Ookura N; Morisaki H; Kobayashi H; Tasaki T; Ushijima H; Yakushiji M
    Igaku Kenkyu; 1984 Dec; 54(8):796-800. PubMed ID: 6599577
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood and urinary values of CEA and CA 19-9 in patients with bladder carcinoma].
    Cicigoi A; Rocca Rossetti S; Piantino P; Cerchier A
    Minerva Med; 1986 Nov; 77(42-43):1983-7. PubMed ID: 3464851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The comparative study of biological behavior between primary lesion and metastatic lymph node of gastric cancer--immunohistochemical study of CEA and CA 19-9].
    Takahashi Y; Minami S; Mai M
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2233-4. PubMed ID: 3459399
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new carbohydrate antigen CA 19-9 associated with malignancies of digestive system. I. Modification of its method and reference values].
    Sakurabayashi I; Kawai T; Yamanaka T; Kimura K; Yagisawa K; Igarashi S; Yonezawa M; Ioku A
    Rinsho Byori; 1984 May; 32(5):539-45. PubMed ID: 6592377
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of the determination of serum CA19.9 in patients with tumor or non-tumor pancreatopathies].
    Encabo G; Ruibal A; Gefaell R; Martínez Miralles E; Salgado A; Fernández Llamazares J
    Med Clin (Barc); 1984 Mar; 82(12):560-1. PubMed ID: 6588282
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serial changes in serum CA 19-9 levels in pancreatic cancer].
    Saito K; Tajiri H; Yoshimori M; Hijikata A; Ohkura H; Nakamura K; Ozaki H
    Gan No Rinsho; 1987 Aug; 33(9):1057-60. PubMed ID: 3476762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of a new tumor marker, CA 15-3, in breast cancer; a comparative study with CEA].
    Komuro K; Watanabe K; Ishida T; Sakurai M; Amano R; Hagiwara H; Hara Y; Hanzawa T; Itsubo K
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3145-9. PubMed ID: 3465273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CA 19-9, a new tumor marker].
    Akai S
    Rinsho Byori; 1983 Dec; 31(12):1300-2. PubMed ID: 6587136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.